Kiadis announces results for the six months ended June 30, 2020 and significant progress made to date in 2020 in all development programs

    NEXT STORY
    Stabilitech Biopharma announces name change to iosBio
    PREV STORY
    Global Esoteric Testing Market Is Expected to Reach USD 56.51 billion by 2027 : Fior Markets
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Survey Finds Louisiana Residents Optimistic on Improving Individual Health; Struggle with Daily Routine, and Experience Cultural Obstacles

    author_avatar
    NASDAQ Market News

    Helius Medical Technologies, Inc. Announces Second Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States

    NEWTOWN, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ...

    author_avatar
    NASDAQ Market News

    Taiwan Liposome Company Reports Positive Top-Line Data from Phase II Clinical Trial of TLC599 in Knee Osteoarthritis Pain

    Primary endpoint and key secondary endpoints metTLC599 demonstrated statistically significant improvement over placebo through  ...

    author_avatar
    NASDAQ Market News